Wu Y, Huang Z, Luo P, Xiang Z, Zhang M, Chen Z
Cancer Metab. 2024; 12(1):30.
PMID: 39456039
PMC: 11520121.
DOI: 10.1186/s40170-024-00359-x.
Jiang W, Yan Z, Zheng X, Huang S, Hu Y, Xiong F
Cell Biochem Biophys. 2024; 82(3):2171-2181.
PMID: 38809351
DOI: 10.1007/s12013-024-01324-7.
Zhang Y, Tedja R, Millman M, Wong T, Fox A, Chehade H
J Ovarian Res. 2023; 16(1):233.
PMID: 38037081
PMC: 10688490.
DOI: 10.1186/s13048-023-01312-0.
Tian P, Deng J, Ma C, Miershali A, Maimaitirexiati G, Yan Q
Oncol Lett. 2023; 27(1):14.
PMID: 38028179
PMC: 10664064.
DOI: 10.3892/ol.2023.14147.
Zhang Y, Tedja R, Millman M, Wong T, Fox A, Chehade H
bioRxiv. 2023; .
PMID: 37986971
PMC: 10659572.
DOI: 10.1101/2023.11.07.566022.
Overexpression of in predicting poor prognosis and promoting the development of lung adenocarcinoma.
Wei D, Sun D, Sirera R, Afzal M, Leong T, Li X
Transl Lung Cancer Res. 2023; 12(7):1517-1538.
PMID: 37577299
PMC: 10413030.
DOI: 10.21037/tlcr-23-306.
Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertension.
Ortega-Ribera M, Gibert-Ramos A, Abad-Jorda L, Magaz M, Tellez L, Paule L
JHEP Rep. 2023; 5(6):100722.
PMID: 37151732
PMC: 10154975.
DOI: 10.1016/j.jhepr.2023.100722.
Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis.
Meng X, Cao R, Liu X, Fu B, Luo L, Jiang M
Oncol Lett. 2023; 25(4):172.
PMID: 36970607
PMC: 10031291.
DOI: 10.3892/ol.2023.13758.
Integrated single-cell and transcriptome sequencing analyses determines a chromatin regulator-based signature for evaluating prognosis in lung adenocarcinoma.
Shi Q, Han S, Liu X, Wang S, Ma H
Front Oncol. 2022; 12:1031728.
PMID: 36324565
PMC: 9618736.
DOI: 10.3389/fonc.2022.1031728.
FLT3LG and IFITM3P6 consolidate T cell activity in the bone marrow microenvironment and are prognostic factors in acute myelocytic leukemia.
Chen H, Wu M, Xia H, Du S, Zhou G, Long G
Front Immunol. 2022; 13:980911.
PMID: 36081495
PMC: 9445253.
DOI: 10.3389/fimmu.2022.980911.
Chromobox 7/8 serve as independent indicators for glioblastoma promoting proliferation and invasion of glioma cells.
Zheng Z, Yuan G, Kang N, Nie Q, Zhang G, Wang Z
Front Neurol. 2022; 13:912039.
PMID: 36034290
PMC: 9403790.
DOI: 10.3389/fneur.2022.912039.
Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7.
Chen J, Zhao Y, Zhang F, Li J, Boland J, Cheng N
Cell Mol Life Sci. 2022; 79(8):443.
PMID: 35867177
PMC: 9307539.
DOI: 10.1007/s00018-022-04452-6.
Chromobox Homologue 7 Acts as a Tumor Suppressor in Both Lung Adenocarcinoma and Lung Squamous Cell Carcinoma via Inhibiting ERK/MAPK Signaling Pathway.
Huang J, Zhang W, Lin D, Lian L, Hong W, Xu Z
Evid Based Complement Alternat Med. 2022; 2022:4952185.
PMID: 35646140
PMC: 9135519.
DOI: 10.1155/2022/4952185.
Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer.
Fang X, Wang J, Chen J, Zhuang M, Huang T, Chen Z
Front Genet. 2022; 13:851390.
PMID: 35464847
PMC: 9019303.
DOI: 10.3389/fgene.2022.851390.
The RNF26/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC.
Liu W, Wang H, Jian C, Li W, Ye K, Ren J
Int J Biol Sci. 2022; 18(5):2132-2145.
PMID: 35342353
PMC: 8935234.
DOI: 10.7150/ijbs.69325.
Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma.
Hu K, Yao L, Zhou L, Li J
Int J Gen Med. 2022; 15:2463-2474.
PMID: 35282653
PMC: 8904945.
DOI: 10.2147/IJGM.S350783.
CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma.
Yang Y, Hu Z, Sun H, Yu Q, Yang L, Yin F
Onco Targets Ther. 2022; 14:5477-5492.
PMID: 34992383
PMC: 8714415.
DOI: 10.2147/OTT.S325203.
Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.
Amirfallah A, Knutsdottir H, Arason A, Hilmarsdottir B, Johannsson O, Agnarsson B
PLoS One. 2021; 16(11):e0260327.
PMID: 34797887
PMC: 8604322.
DOI: 10.1371/journal.pone.0260327.
CBX7 is Dualistic in Cancer Progression Based on its Function and Molecular Interactions.
Li J, Ouyang T, Li M, Hong T, Alriashy M, Meng W
Front Genet. 2021; 12:740794.
PMID: 34659360
PMC: 8517511.
DOI: 10.3389/fgene.2021.740794.
DeepProg: an ensemble of deep-learning and machine-learning models for prognosis prediction using multi-omics data.
Poirion O, Jing Z, Chaudhary K, Huang S, Garmire L
Genome Med. 2021; 13(1):112.
PMID: 34261540
PMC: 8281595.
DOI: 10.1186/s13073-021-00930-x.